Benoit Plancoulaine

Caen, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Long-term patient-derived ovarian cancer organoids closely recapitulate tumor of origin and clinical response.

Long-term patient-derived ovarian cancer organoids closely recapitulate tumor of origin and clinical response.

Journal: Journal of experimental & clinical cancer research : CR

Published: April 01, 2025

Automated Scoring to Assess RAD51-Mediated Homologous Recombination in Ovarian Patient-Derived Tumor Organoids.

Automated Scoring to Assess RAD51-Mediated Homologous Recombination in Ovarian Patient-Derived Tumor Organoids.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: July 23, 2024

Intratumoral heterogeneity of Ki67 proliferation index outperforms conventional immunohistochemistry prognostic factors in estrogen receptor-positive HER2-negative breast cancer.

Intratumoral heterogeneity of Ki67 proliferation index outperforms conventional immunohistochemistry prognostic factors in estrogen receptor-positive HER2-negative breast cancer.

Journal: Virchows Archiv : an international journal of pathology

Published: September 17, 2023

Matrix Metalloproteinase-9 Expression Is Associated with the Absence of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients.

Matrix Metalloproteinase-9 Expression Is Associated with the Absence of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients.

Journal: International journal of molecular sciences

Published: June 20, 2023

Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response.

Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response.

Journal: Cancers

Published: December 05, 2022

A new approach for microstructure imaging.

A new approach for microstructure imaging.

Journal: Scientific reports

Published: June 06, 2022

Impact of automated methods for quantitative evaluation of immunostaining: Towards digital pathology.

Impact of automated methods for quantitative evaluation of immunostaining: Towards digital pathology.

Journal: Frontiers in oncology

Published: April 28, 2022

How the variability between computer-assisted analysis procedures evaluating immune markers can influence patients' outcome prediction.

How the variability between computer-assisted analysis procedures evaluating immune markers can influence patients' outcome prediction.

Journal: Histochemistry and cell biology

Published: August 02, 2021

Machine-Learning-Based Evaluation of Intratumoral Heterogeneity and Tumor-Stroma Interface for Clinical Guidance.

Machine-Learning-Based Evaluation of Intratumoral Heterogeneity and Tumor-Stroma Interface for Clinical Guidance.

Journal: The American journal of pathology

Published: March 16, 2021

Intranuclear birefringent inclusions in paraffin sections by polychromatic polarization microscopy.

Intranuclear birefringent inclusions in paraffin sections by polychromatic polarization microscopy.

Journal: Scientific reports

Published: November 24, 2020

Peritumoral immune infiltrates in primary tumours are not associated with the presence of axillary lymph node metastasis in breast cancer: a retrospective cohort study.

Peritumoral immune infiltrates in primary tumours are not associated with the presence of axillary lymph node metastasis in breast cancer: a retrospective cohort study.

Journal: PeerJ

Published: March 12, 2020

Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast Carcinoma.

Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast Carcinoma.

Journal: Frontiers in oncology

Published: February 23, 2020

Showing 1-12 of 29

Last Updated: 09/26/2026